References
- Schurek K, Wiebe R, Karlowsky J, et al. Faropenem: review of a new oral penem. Expert Rev Anti Infect Ther 2007;5:185–98
- Dalhoff A, Thomson C. The art of fusion: from penams and cephems to penems. Chemotherapy 2003;49:105–20
- Dalhoff A, Janjic N, Echols R. Redefining penems. Biochem Pharmacol 2006;71:1085–95
- Papp-Wallace K, Endimiani A, Taracila M, Bonomo R. Carbapenems: past, present, and future. Antimicrob Agents Chemother 2011;55:4943–55
- Wexler H, Molitoris D, John S, et al. In vitro activities of faropenem against 579 strains of anaerobic bacteria. Antimicrob Agents Chemother 2002;46:3669–75
- Milatovic D, Schmitz F, Verhoef J, Fluit A. In vitro activity of faropenem against 5460 clinical bacterial isolate from Europe. J Antimicrob Chemother 2002;50:293–9
- Behra-Miellet J, Dubreuil L, Bryskier A. In vitro evaluation of faropenem activity against anareobic bacteria. J Chemother 2005;17:36–45
- Hamilton-Miller J. Chemical and microbiological aspects of penem, a distinct class of β-lactams: focus on faropenem. Pharmacotherapy 2003;23:1497–507
- Cielecka-Piontek J, Michalska K, Zalewski P, Jelińska A. Recent advances in stability studies of carbapenems. Curr Pharm Anal 2011;7:213–27
- Cielecka-Piontek J, Michalska K, Zalewski P, Zasad S. Comparative review of analytical techniques for determination of carbapenems. Curr Anal Chem 2011;7:213–21
- Cielecka-Piontek J, Jelińska A, Dołhań A, Zalewski P. Kinetic and thermodynamic analysis of degradation of doripenem in solid state. Int J Chem Kinet 2012;44:722–8
- Gao S, Chen W, Tao X, et al. Determination of faropenem in human plasma and urine chromatography-tandem mass spectrometry. Biomed Chromatogr 2008;22:5–12
- Menon S, Panchal J, Patel R. Development and validation of a stability indicating LC method for the determination of faropenem in pharmaceutical formulations. Chromatographia 2009;69:1013–18
- Xie R, Wen J, Wei H, et al. High-throughput determination of faropenem in human plasma and urine by on-line solid-phase extraction coupled to high-performance liquid chromatography with UV detection and its application to the pharmacokinetic study. J Pharm Biomed Anal 2010;52:114–21
- Cielecka-Piontek J, Lewandowska K, Barszcz B, Paczkowska M. The use of UV, FT-IR and Raman spectra for the identification of the newest penem analogs: solutions based on mathematic procedure and the density functional theory. Spectrochim Acta A Mol Biomol Spectrosc 2012. [Epub ahead of print]. doi: dx.doi.org/10.1016/j.saa.2012.09.035.y
- Frisch M, Trucks G, Schlegel H, et al. Gaussian 03, Revision B.05. Pittsburgh, PA: Gaussian Inc; 2003
- Richardson G, Malthus R. Salts for static control of humidity at relatively low levels. J Appl Chem 1955;5:557–67
- Otsuka M, Tanabe H. Stability test for amorphous materials in humidity controlled 96-well plates by near-infrared spectroscopy. Drug Dev Ind Pharm 2012;38:380–5
- Refat H, Alhalaweh A, Velaga S. Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin. Drug Dev Ind Pharm 2012. [Epub ahead of print]. doi: 10.3109/03639045.2012.671831
- Hassan N, Abdel-Moety E, Elragehy N, Rezk M. Selective determination of ertapenem in the presence of its degradation product. Spectrochim Acta A Mol Biomol Spectrosc 2009;72:915–21
- Sajonz P, Natishan T, Wu Y, et al. Preparation, isolation, and characterization of dimeric degradation products of the 1β-methylcarbapenem antibiotics, ertapenem. J Liq Chromatogr Related Technol 2001;24:2999–3015
- Xia M, Hang T, Zhang F, et al. The stability of biapenem and structural identification of impurities in aqueous solution. J Pharm Biomed Anal 2009;49:937–44
- Elragehy N, Abdel-Moety E, Hassan N, Rezk M. Stability-indicating determination of meropenem in presence of its degradation product. Talanta 2008;77:28–32